Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
06/2008
06/11/2008CN101198253A Combinations, methods and compositions for treating cancer
06/11/2008CN100393713C Therapeutic agents useful for treating pain
06/11/2008CN100393706C Substituted dihydrochinazolines having antiviral properties
06/11/2008CN100393703C 1,2,3,4-tetrahydroisoquinoline derivatives
06/10/2008US7385063 Method for preparing imidazole derivatives
06/10/2008US7385053 Functionalized compositions for improved immobilization
06/10/2008US7384973 Materials and methods for treating hypercholesterolemia
06/10/2008US7384929 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof
06/10/2008CA2296665C Triazolo[4,5-d]pyrimidine derivatives as anti-thromobotic agents
06/05/2008WO2008067440A2 Rosuvastatin dehydroabietylamine salt
06/05/2008WO2008067219A2 Quinazolinone modulators of tgr5
06/05/2008WO2008065445A1 Amino quinazolines derivatives wuth blood platelet reducing properties
06/05/2008WO2008065410A1 Process for the preparation of rosuvastatin
06/05/2008WO2008065393A1 Hydantoin derivatives used as mmp inhibitors
06/05/2008US20080132706 Compounds as PDE IV and TNF Inhibitors
06/05/2008US20080132699 Process For the Preparation of Diazine Derivatives
06/05/2008US20080132698 Use of N-oxide compounds in coupling reactions
06/05/2008US20080132561 Materials and Methods for Treating Hypercholesterolemia
06/05/2008US20080132514 bi-functional organic molecules which combine serotonin transporter reuptake inhibition with serotonin (5-HT, such as 5-HT2A) receptor antagonism in one molecular entity
06/05/2008US20080132513 new mechanism of action, oral bioavailability and/or reduced side effects; Ca2+-release-activated Ca2+ channels inhibitors; IL-2, IL-4, IL-5, IL-13, GM-CSF, TNF- alpha , and IFN gamma inhibitors; immunosuppressant
06/05/2008US20080132507 Hydrazide Derivatives
06/05/2008US20080132504 2, 4-Pyrimidinediamines Useful In The Treatment Of Neoplastic Diseases, Inflammatory And Immune System Disorders
06/05/2008US20080132499 Platelet adp receptor inhibitors
06/05/2008US20080132497 Novel Heterocycles
06/05/2008US20080132412 7-Amino-6-Heteroaryl-1,2,4-Triazolo[1,5-A]Pyrimidines and Their Use for Controlling Harmful Fungi
06/05/2008DE19946341B4 Verfahren zur Herstellung substituierter Phenylsulfonylharnstoffe aus Sulfohalogeniden A process for the preparation of substituted phenylsulfonylureas of Sulfohalogeniden
06/05/2008CA2670456A1 Process for the preparation of rosuvastatin
06/05/2008CA2670168A1 Amino quinazolines derivatives wuth blood platelet reducing properties
06/05/2008CA2670166A1 Hydantoin derivatives used as mmp inhibitors
06/04/2008EP1927594A1 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
06/04/2008EP1926716A1 Process for synthesis of aryloxy diaminopyrimidines
06/04/2008EP1926715A1 Pesticide pyrimidinyloxy substituted phenylamidine derivatives
06/04/2008EP1926500A2 Methods of making radiolabeled tracers and precursors thereof
06/04/2008EP1841745B1 Process for the manufacture of a precursor of vitamin b1
06/04/2008EP1395591B1 Corticotropin releasing factor antagonists
06/04/2008EP1368412B1 Imageable element and composition comprising thermally reversible polymers
06/04/2008EP1204643B1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
06/04/2008EP1193250B1 Phenyl sulfamate derivatives
06/04/2008CN101193985A Cyanine coloring matter and optical recording medium
06/04/2008CN101193868A Pyrimidine derivatives for the treatment of GABA B mediated nervous system disorders
06/04/2008CN101193635A Multicyclic compounds and methods of their use
06/04/2008CN101190899A Method for synthesizing 1.2-dihydroquinazolin-4(3H)-one compound
06/04/2008CN101190898A Preparation method for 1.3-dimethylbarbituric acid
06/04/2008CN101190897A Method for synthesizing 4-(4-fluorophenyl)-6-isopropyl-2-methylaminopyrimidine-5-formic acid ester
06/04/2008CN100391959C Pyrimidine-5-(1H)-ketone derivative
06/03/2008US7381828 Forming a salt such as a tartrate or mandelate of 6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]-dioxol-4-yl]oxy}-1-ethanol, chemical intermediates
06/03/2008US7381730 Bone disorders, cardiovascular diseases, anticholesterol agents, hypertriglyceridemia, vasomotor disorders, urogenital disorders, prostatic hypertrophy, endometrial hyperplasia, anticarcinogenic agents; CNS disorders; side effect reduced
06/03/2008US7381723 Antiserotonine agents; stroke, brain disorders;trauma; Alzheimer's disease; neurodegenerative disease; schizophrenia; psychological disorders; anxiolytic agents; controlling stresses; eating disorders; sleep disorders; sexual disorders
06/03/2008CA2389360C Urea derivatives as anti-inflammatory agents
06/03/2008CA2203237C Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
05/2008
05/29/2008WO2008063668A1 Heterobicyclic metalloprotease inhibitors
05/29/2008WO2008062907A1 Substance capable of inhibiting cytokinin signaling
05/29/2008WO2008062859A1 Process for production of phenylalanine derivatives having quinazolinedione skeletons and intermediates for the production
05/29/2008WO2008062276A2 Acetylene derivatives as stearoyl coa desaturase inhibitors
05/29/2008WO2008062044A1 2-hydroxy-1,3-diaminopropane derivatives
05/29/2008WO2008062011A1 Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods
05/29/2008WO2008061740A1 Pyrimidines and their use as cxcr2 receptor antagonists
05/29/2008US20080125589 Process for Production of Fluoro Derivative
05/29/2008US20080125468 Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
05/29/2008US20080125449 hypotensive agent; cardiovascular disease; 5-ethoxycarbonyl-4-(2-ethoxy-6-pentadecylphenyl)-6-methyl-3,4 -dihydropyrimidin-2(1H)-one;
05/29/2008US20080125448 Quinazoline Based EGFR Inhibitors Containing a Zinc Binding Moiety
05/29/2008US20080125429 1-{[5-[4-(Methylsulfonyl)phenoxy]-2-(2-pyridinyl)-1H-benzimidazol-6-yl]methyl}-5-thioxo-2-pyrrolidinone;glucokinase activator; antidiabetic agents; obesity; prevention of retinopathy, nephropathy, neurosis, ischemic cardiopathy, arteriosclerosis; antiischemic agents; cardiotonic agents
05/29/2008US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics
05/29/2008US20080125417 4-Tert-Butyl-N-(2-methyl-3-{2-[4-(morpholine-4-carbonyl)-phenylamino]-pyrimidin-4-yl}-phenyl)-benzamide;enzyme inhibitors of Burton's tyrosine kinase (Btk); autoimmune diseases; antiinflammatory/-arthritic agents; X-linked agammaglobulinaemia; antiallergens; osteoporosis; determining the presence Btk
05/29/2008US20080124384 Heteroaryl Substituted Piperazinyl-Pyridine Analogues
05/29/2008CA2670143A1 Pyrimidines and their use as cxcr2 receptor antagonists
05/29/2008CA2670031A1 Heterobicyclic metalloprotease inhibitors
05/29/2008CA2669839A1 2-hydroxy-1,3-diaminopropane derivatives
05/29/2008CA2669275A1 Agent for inhibiting cytokinin signaling
05/29/2008CA2668567A1 Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods
05/28/2008EP1924573A1 B-raf inhibitors
05/28/2008EP1924568A1 Quinazoline derivatives useful in cancer treatment
05/28/2008EP1924567A2 Process for the preparation of pyrimidinedione derivatives
05/28/2008EP1924566A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators
05/28/2008EP1924565A1 Diaminopyrimidines as p2x3 and p3x2/3 modulators
05/28/2008EP1924564A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators
05/28/2008EP1556382B1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof
05/28/2008EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
05/28/2008EP1404668B1 Variolin derivatives and their use as antitumor agents
05/28/2008CN100390235C Azo compound and process of producing the same, amd novel compound and process of producing azo compounds using the same
05/28/2008CN100390146C Process for making risperidone and intermediates therefor
05/28/2008CN100390135C Novel derivatives of dicarboxylic acid having pharmaceutical properties
05/27/2008US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
05/27/2008US7378522 Such as 6-(4-Acetamidophenoxy)-5-(N-benzyl-N-methylaminomethyl)-1-(2',6'-difluorobenzyl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid-ethyl ester; rapid effectiveness, bioavailability; low cost, simple synthesis
05/27/2008US7378446 1-((4,14-(Dioxo),5-(1-hydroxy,1,2-dicarboxyethyl)),3-azaoctadec-6-enyl-),4-(phenoxy)benzene derivatives and salts ; extremely potent replication inhibitory activity against the hepatitis C virus (HCV); chronic hepatitis, cirrhosis and liver cancer; mild cytotoxicity in vitro; prophylaxis; prodrugs
05/27/2008US7378424 Derivatives of pyrimido[6, 1-A]isoquinolin-4-one
05/27/2008US7378422 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
05/27/2008US7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
05/22/2008WO2008059519A2 A process for the preparation of intermediates of rosuvastatin
05/22/2008WO2008059024A1 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes
05/22/2008WO2006055561A3 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
05/22/2008US20080119651 Process For The Production Of Pyrimidine-5-Carboxylates
05/22/2008US20080119486 Benzoyl-piperazine derivatives
05/22/2008US20080119473 3-[4-(4-Fluoro-phenyl)-[1,3,5]triazin-2-yl]-benzoic acid; suppressing premature translation termination associated with nonsense mutation in an mRNA; diseases associated with nonsense mutations in mRNA; antiinflammatory, anticarcinogenic, antidiabetic agent; autoimmune, neurodegenerative diseases
05/22/2008US20080119470 8-hydroxy-3H-quinazolin-4-(thi)one derivatives; ability to enter CNS, sequester transition metals Cu, Zn and Fe from various amiloid beta entities, reducing their toxicity; neurodegenerative disorders; Alzheimer's, Parkinson's, Cruetzfeldt-Jacob diseases, amyotrophic lateral sclerosis, cataract
05/22/2008CA2669867A1 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes
05/22/2008CA2666837A1 Arylsulfonamide compounds
05/21/2008EP1923390A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
05/21/2008EP1922309A1 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
05/21/2008EP1922306A2 Amide derivatives as rock inhibitors